Journal of Liver

2^nd International Conference on Hepatology

May 09-11, 2016 Chicago, USA

Posters & Accepted Abstracts

• The increment of platelet count is a risk factor of pulmonary thromboembolism in patients with pancreatic cancer treated with gemcitabine

  Ho Gak Kim, Dong Wook Lee and Jimin Han

  PDF HTML

• Niclosamide blocks glucagon phosphorylation of serine 552 on β-catenin leading to a reduction in cyclin D1 and c-Myc expression in primary rat hepatocytes via PKA signaling

  Md Kamrul Hasan Chowdhury

  PDF HTML

• A lipidomic analysis for Non-Alcoholic Steatohepatitis (NASH)

  Parul Verma, Jingmei Lin, Naga Chalasani, Doraiswami Ramkrishna and Wanqing Liu

  PDF HTML

• A lipidomic analysis for Non-Alcoholic Steatohepatitis (NASH)

  Parul Verma, Jingmei Lin, Naga Chalasani, Doraiswami Ramkrishna and Wanqing Liu

  PDF HTML

• Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients

  Ekram Wassim Abd El-Wahab, Ashraf Mikheal, Fath Allah Sidkey and Hanan Zakaria Shatat

  PDF HTML

• Ligase chain reaction as a modality for the detection of point mutation in the precore region of HBV related HCC cases from northern India

  Abdul Malik

  PDF HTML

• Knowledge and behaviors of self-care of the liver transplanted patients

  H E Liu and Y F Lin

  PDF HTML

• Therapy with sartans significantly prolongs overall survival and delays time to recurrence in patients undergone radiofrequency ablation of hepatocarcinoma nodules

  Barone Michele and Facciorusso Antonio

  PDF HTML

• Percutaneous US-guided radiofrequency ablation of early hepatocellular carcinoma today

  Fabio Fornari

  PDF HTML

• Acquired familial amyloid polyneuropathy after domino liver transplantation

  Elia Maria dos Santos Mateus

  PDF HTML

• Viewing cellular origin of intrahepatic cholangiocarcinoma from perspective of tumor heterogeneity

  Zhaohui Tang

  PDF HTML

• p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration

  Guadalupe Sabio

  PDF HTML

• Genetic polymorphisms of APOBEC3A/B may influence the risk of HBV related HCC via affecting viral mutations: Key steps to interpret cancer Evo-Devo

  Guangwen Cao

  PDF HTML

• MiR-22 silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor

  Hui Xin Liu, Ying Hu and Yu Jui Yvonne Wan

  PDF HTML

• Metabolic reprogramming is a very early event in HCC development

  Amedeo Columbano

  PDF HTML

• Molecular links between inflammation, NAFLD and HCC in the context of Ncoa5 deficiency

  Hua Xiao

  PDF HTML

• Liver diseases in pregnancy

  Jamile Wakim-Fleming

  PDF HTML

• Two novel nonnucleosidic compounds inhibit hepatitis B virus replication by inducing genomefree capsid formation

  Jian-Ping Zuo

  PDF HTML

• Anti-PLVAP monoclonal antibody derived therapeutics for hepatocellular carcinoma

  K J Kao, Yun-Hsing Wang, Vincent P Chuang and Andrew T Huang

  PDF HTML

• The effects of 4-nonylphenol administration induced oxidative damages in liver and contributes to hepatic steatosis in male rats

  Ansoumane Kourouma

  PDF HTML

• CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma

  Wenbin Li, Zeyu Lin and Jie Wang

  PDF HTML

• Pathological staging of hepatic fibrosis predict the phase two of ALLPPS can be done or not?

  Li Wenbin and Jie Wang

  PDF HTML

• Recurrence of hepatocellular carcinoma after living donor liver transplantation (single center experience)

  Nada Maher El-Domiaty

  PDF HTML

• The clinicopathological spectrum of liver pathology in a high HIV/AIDS burden country

  Mark Sonderup

  PDF HTML

• The potential use of saliva and dried blood spot for viral hepatitis diagnosis

  Livia Melo Villar

  PDF HTML

• A proteomic approach for the involvement of the ANXA4 in HCC: Moving towards an understanding of tumor progression

  Nikhat Ahmed Siddiqui, Shamim Mushtaq, Been Hasan, Ayesha Khan, Meraj Zehra, Ayesha Siddiqui, Sobia Manzoor and M A Rahman

  PDF HTML

• Advances in pharmacotherapy for primary biliary cirrhosis

  Pietro Invernizzi

  PDF HTML

• Hippo signaling in liver development, homeostasis, and disease

  Randy L Johnson

  PDF HTML

• Bile acid signaling activates MiR-26a to regulate insulin sensitivity and metabolism of glucose and lipids

  Wendong Huang

  PDF HTML

• Gut microbiota are disturbed in patients with Budd-Chiari syndrome in China

  Yuling Sun

  PDF HTML